
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GLPG | Amsterdam | EUR | Real-time | |
GLPGa | BATS Europe | EUR | Delayed | |
GLPGF | OTC Markets | USD | Delayed | |
GLPG | NASDAQ | USD | Real-time | |
GLPG | TradeGate | EUR | Delayed | |
GLPG | Vienna | EUR | Real-time |
Index | Last | High | Low | Chg. | Chg. % | Time | ||
---|---|---|---|---|---|---|---|---|
Health Care NR | 6,349.30 | 6,349.30 | 6,349.30 | +94.74 | +1.51% | 16:35:59 | ||
AEX All Share | 1,171.93 | 1,177.25 | 1,170.70 | -0.10 | -0.01% | 16:35:59 | ||
AMX | 903.21 | 904.57 | 900.18 | +7.69 | +0.86% | 16:35:59 | ||
Next 150 | 3,660.06 | 3,670.78 | 3,639.60 | +21.57 | +0.59% | 16:35:59 | ||
Next Biotech | 3,279.76 | 3,279.76 | 3,279.76 | +38.70 | +1.19% | 16:35:59 | ||
AEX Health Care | 1,348.08 | 1,363.65 | 1,346.54 | -10.68 | -0.79% | 16:35:59 | ||
STOXX 600 | 541.40 | 543.64 | 540.60 | +0.80 | +0.15% | 17:00:17 | ||
BEL 20 GR | 15,536.90 | 15,536.90 | 15,536.90 | +188.11 | +1.23% | 16:35:59 | ||
BEL 20 Net Return | 11,323.60 | 11,323.60 | 11,323.60 | +137.10 | +1.23% | 16:35:59 | ||
BEL Continuous Stocks Net Return | 59,132.72 | 59,356.21 | 58,634.96 | +497.80 | +0.85% | 16:35:59 | ||
BEL All Share Net Return | 63,726.18 | 63,726.18 | 63,726.18 | +534.98 | +0.85% | 16:35:59 | ||
BEL All Share | 14,717.67 | 14,773.38 | 14,594.13 | +123.55 | +0.85% | 16:35:59 | ||
STXE Health Care PR | 1,002.31 | 1,003.53 | 992.39 | +1.20 | +0.12% | 04/08 | ||
AMX Gross | 3,285.53 | 3,290.50 | 3,274.51 | +27.96 | +0.86% | 16:59:45 | ||
EN BENE 40 EW | 3,017.01 | 3,028.80 | 3,007.84 | +17.47 | +0.58% | 16:35:59 | ||
BEL 20 X5 Leverage NR | 643.74 | 658.93 | 622.04 | +37.03 | +6.10% | 16:35:59 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review